Back to results
US 2026/0248831 A1Published application
Non-tuberculosis mycobacteria infection treatment
AssigneeAN2 Therapeutics, Inc.
InventorsMichael Richard Kevin ALLEY, Eric Edward EASOM, Paul Brian ECKBURG, Kevin Michael KRAUSE, George H. TALBOT
Life of this patent
Estimating the term…
Abstract
The present invention is directed to methods of achieving a positive therapeutic response against an infection by non-tuberculosis Mycobacteria (NTM) through administering an oral dose of epetraborole to a human subject.
Claims36
A method of achieving a positive therapeutic response against a non-tuberculosis Mycobacteria (NTM) infection, comprising:
- administering to a human in need thereof
- epetraborole, or a hydrate, solvate, or pharmaceutically acceptable salt thereof, and
- ethambutol or a hydrate, solvate, or pharmaceutically acceptable salt thereof, thereby achieving the positive therapeutic response.
-10. (canceled)
-24. (canceled)
-32. (canceled)
(canceled)
(canceled)
-40. (canceled)
-49. (canceled)
(canceled)
(canceled)
(canceled)
-59. (canceled)
-66. (canceled)
Dependencies are inferred from the claim text.